Calliditas Therapeutics AB (publ)
CLTEF · OTC
5/31/2025 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$976,666 | -$466,185 | -$39,514 | -$55,306 |
| Dep. & Amort. | $272,367 | $16,594 | $1,238 | $714 |
| Deferred Tax | $0 | $0 | $5,640 | -$1,028 |
| Stock-Based Comp. | $0 | $52,591 | $3,430 | $2,428 |
| Change in WC | $61 | -$79,741 | -$9,070 | -$1,400 |
| Other Non-Cash | $704,124 | $42,086 | -$273,078 | -$406,996 |
| Operating Cash Flow | -$1,099,190 | -$434,655 | -$29,842 | -$51,028 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$12,788 | -$241 | -$728 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$957 | -$4,903 | -$23,612 |
| Investing Cash Flow | $0 | -$13,745 | -$5,144 | -$24,340 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $6,209 | $226,276 | $482,130 | $193,949 |
| Stock Issued | $84 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | -$236 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$6,166 | -$26,626 | $94,096 | $241,213 |
| Financing Cash Flow | $127 | $199,650 | $575,990 | $435,162 |
| Forex Effect | -$0 | -$26,611 | $34,094 | $9,969 |
| Net Chg. in Cash | $12 | -$275,361 | $14,090 | -$40,797 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $11 | $1,249,094 | $105,629 | $121,104 |
| End Cash | $23 | $973,733 | $119,719 | $105,629 |
| Free Cash Flow | -$1,099,190 | -$447,443 | -$30,082 | -$51,756 |